Retrospective cohort study examines how changes in luteinizing hormone during ovulation induction affect IVF and ICSI results in POSEIDON groups, suggesting optimized outcomes.
Objective To investigate the impact of changes in luteinizing hormone (LH) levels during ovulation induction using flexible gonadotropin-releasing hormone antagonist (GnRH-A) regimens in POSEIDON groups 1 and 2 on the clinical outcomes of fresh in-vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycles. Method A retrospective analysis was conducted on the clinical data of females in POSEIDON groups 1 and 2 who underwent IVF/ICSI using a flexible GnRH-A regimen at the Reproductive Medicine Center of Fujian Maternal and Child Health Hospital from January 2017 to December 2022. According to the values of change in LH [(LH level on the trigger day − baseline LH)/baseline LH] × 100%, the study subjects were divided into five groups. The general information, laboratory indicators, and clinical outcomes of each group were compared. Results In POSEIDON group 1, a significant difference was observed in terms of the number of retrieved eggs, mature eggs, fertilization number (two pronuclei (2PN) number), and cleavage among all groups (all P values < 0.05). In POSEIDON group 2, a significant difference was observed in terms of the number of retrieved eggs, mature eggs, fertilization number (2PN number), cleavage, excellent embryos, and blastocysts (all P values < 0.05). The number of eggs retrieved in group A was significantly lower than that in groups D and E ( P = 0.010 and 0.001, respectively). The number of mature eggs in group A was significantly lower than that in groups D and E ( P = 0.008 and 0.000, respectively). The number of mature eggs in group E was significantly higher than that in groups B and C ( P = 0.033 and 0.021, respectively). The 2PN number in group A was significantly lower than that in groups D and E ( P = 0.042 and 0.002, respectively). The cleavage count of group E was significantly higher than that of groups A and C ( P = 0.005 and 0.037, respectively). The excellent embryos in group B were significantly lower than those of group E ( P = 0.038). Conclusion The use of a flexible GnRH-A regimen to induce ovulation in the POSEIDON groups 1 and 2 can lead to better-controlled ovarian stimulation (COS) outcomes. This involves the LH level on trigger day decreasing within the range of 0–100% from baseline (with optimal range being ≥ −100% to −50%). This trend was more obvious in the POSEIDON group 2 population.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: